Doximity Total Liabilities and Share Holders Equity 2020-2025 | DOCS
Doximity total liabilities and share holders equity from 2020 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Doximity total liabilities and share holders equity for the quarter ending March 31, 2025 was $1.264B, a 17.13% increase year-over-year.
- Doximity total liabilities and share holders equity for 2025 was $1.264B, a 17.13% increase from 2024.
- Doximity total liabilities and share holders equity for 2024 was $1.079B, a 5.06% decline from 2023.
- Doximity total liabilities and share holders equity for 2023 was $1.137B, a 14.68% increase from 2022.
| Doximity Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2025 | $1,264 |
| 2024 | $1,079 |
| 2023 | $1,137 |
| 2022 | $991 |
| 2021 | $252 |
| 2020 | $139 |
| 2019 | $0 |
| Doximity Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,264 |
| 2024-12-31 | $1,172 |
| 2024-09-30 | $1,119 |
| 2024-06-30 | $1,073 |
| 2024-03-31 | $1,079 |
| 2023-12-31 | $1,001 |
| 2023-09-30 | $1,026 |
| 2023-06-30 | $1,154 |
| 2023-03-31 | $1,137 |
| 2022-12-31 | $1,067 |
| 2022-09-30 | $1,028 |
| 2022-06-30 | $1,051 |
| 2022-03-31 | $991 |
| 2021-12-31 | $932 |
| 2021-09-30 | $869 |
| 2021-06-30 | $830 |
| 2021-03-31 | $252 |
| 2020-12-31 | $252 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $139 |
| 2019-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $10.774B | $0.570B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.769B | 58.23 |
| Hims & Hers Health (HIMS) | United States | $14.374B | 149.35 |
| Tempus AI (TEM) | United States | $11.826B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.653B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.861B | 60.33 |
| Hinge Health (HNGE) | United States | $3.282B | 0.00 |
| Privia Health (PRVA) | United States | $2.664B | 182.08 |
| Enovis (ENOV) | United States | $1.720B | 9.59 |
| Phreesia (PHR) | United States | $1.560B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Schrodinger (SDGR) | United States | $1.501B | 0.00 |
| Azenta (AZTA) | United States | $1.357B | 63.06 |
| 10x Genomics (TXG) | United States | $1.331B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Evolent Health (EVH) | United States | $1.086B | 92.50 |
| Claritev (CTEV) | United States | $0.657B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.448B | 134.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.251B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| CareCloud (CCLD) | United States | $0.106B | 4.03 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.094B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |